102151-53-1

Upstream product

• 126007-96-3 2-(4-benzyloxy-phenyl)-5-trifluoromethyl-1H-imidazole 
• 4397-53-9 p-benzyloxybenzaldehyde 
• 431-67-4 1,1-dibromo-3,3,3-trifluoroacetone 

Downstream Products

• 884874-87-7 2-(4-benzyloxy-phenyl)-3H-imidazole-4-carboxylic acid N-(3-hydroxybenzyl)amide 
• 102152-28-3 (S)-4-carbethoxy-2-<4-<3-<<2-(3,4-dimethoxyphenyl)ethyl>amino>-2-hydroxypropoxy>phenyl>imidazole 
• 102152-23-8 2-<4-<3-<<2-(3,4-dimethoxyphenyl)ethyl>amino>-2-hydroxypropoxy>phenyl>-4-(ethoxymethyl)imidazole 
• 102281-28-7 (S)-2-<4-<3-<<2-(3,4-dimethoxyphenyl)ethyl>amino>-2-hydroxypropoxy>phenyl>-4-(methoxymethyl)imidazole 
• 102151-56-4 1-benzyl-2--4-methoxymethylimidazole 
• 102151-55-3 1-benzyl-2--4-hydroxymethylimidazole 
• 102151-69-9 4-carbethoxy-2-(4-hydroxyphenyl)imidazole 
• 102151-57-5 2-(4-hydroxyphenyl)-4-(methoxymethyl)imidazole 
• 102151-54-2 1-benzyl-2--4-carbobenzoxyimidazole 
• 102151-68-8 2--4-carbetoxyimidazole 

Relevant academic research and scientific papers

HETEROCYCLIC CARBONYL COMPOUNDS

The invention relates to novel heterocyclic compounds of formula (I) wherein R1, D, W, T and T' have the meaning cited in the claim 1. Said compounds are SGK-inhibitors and can be used in the treatment of SGK-related diseases and disorders such as diabetes, obesity, metabolic syndrome (dyslipidemia), systemic and pulmonal hypertension, cardiovascular diseases and renal diseases, and generally for any kind of fibroses and inflammatory processes.

β1-Selective Adrenoceptor Antagonists: Examples of the 2-phenyl>imidazole Class. 2

An attempt to develop a highly cardioselective β-adrenoceptor antagonist devoid of intrinsic sympathomimetic activity (ISA) focused on exploring structure-activity relationships around (S)--amino>-2-hydroxypropoxy>phen